NEW YORK (Reuters Health) - Testing for the prostate cancer gene 3 (PCA3) in urine may improve screening for prostate cancer, new research suggests.Screening for prostate cancer usually involves measuring a protein in the blood called prostate specific antigen or PSA. High PSA levels suggest that cancer may be present and a biopsy is then performed to confirm the diagnosis.>>> Discuss This Story
